ACE-031

Description:

ACE-031 is a peptide that functions as an ActRIIB antagonist. ActRIIB (Activin Receptor Type IIB) is a receptor in the body that regulates the growth of muscle tissue, and ACE-031 works by blocking this receptor, leading to increased muscle mass and muscle strength. This peptide has been studied primarily for its potential in muscle wasting conditions such as muscular dystrophy, sarcopenia, and for muscle growth enhancement in athletic and bodybuilding contexts.

ACE-031 is not currently FDA-approved but has been used in research settings to explore its role in muscle regeneration and enhancement.

Key Benefits:

• Increases muscle mass and strength by inhibiting ActRIIB

• Potential treatment for muscle wasting and degenerative muscle diseases

• Enhances muscle regeneration and recovery after exercise or injury

• Increased muscle fiber size and muscle density

• Improved athletic performance and strength potential

Mechanism of Action:

• ACE-031 blocks the Activin Receptor Type IIB (ActRIIB), which naturally inhibits muscle growth via the myostatin pathway.

• By inhibiting myostatin, ACE-031 increases muscle growth and can lead to enhanced muscle regeneration.

• Myostatin is a negative regulator of muscle growth, and by interfering with this pathway, ACE-031 helps increase muscle cell differentiation and protein synthesis, contributing to muscle hypertrophy.

Dosage & Administration:

• Form: Reconstitute lyophilized powder with bacteriostatic water

• Injection Method: Subcutaneous, typically in the fatty tissue around the abdomen or thigh

• Typical Dosage:

  • Initial: 0.5–1.0 mg per day for muscle growth

  • Maintenance: 1–2 times per week, depending on the cycle

• Cycle Length: Typically 4–6 weeks, followed by a rest period to prevent downregulation